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Effects and Dose Response Relation-
ships of Skin Cancer and Blackfoot
Disease with Arsenic
by Wen-Ping Tseng*
In a limited area on the southwest coast ofTaiwan, where artesian well water with a high concentration
of arsenic has been used for more than 60 years, a high prevalence of chronic arsenicism has been
observed in recent years. The total population of this "endemic" area is approximately 100,000. A
general survey of 40,421 inhabitants and follow-up of 1,108 patients with blackfoot disease were made.
Blackfoot disease, so-termed locally, is a peripheral vascular disorder resulting in gangrene of the ex-
tremities, especially the feet. The overall prevalence rates for skin cancer was 10.6 per 1000, and for
blackfoot disease 8.9 per 1000. Generally speaking, the prevalence increased steadily with age in both
diseases. The prevalence rates for skin cancer and blackfoot disease increased with the arsenic content of
well water, i.e., the higher the arsenic content, the more patients with skin cancer and blackfoot disease.
A dose-response relationship between blackfoot disease and the duration ofwater intake was also noted.
Furthermore, the degree of permanent impairment of function in the patient was directly related to
duration ofintake ofarsenical water and to duration ofsuch intake at the time ofonset. The mostcommon
cause ofdeath in the patients with skin cancer and blackfoot disease was carcinoma ofvarious sites. The
5-year survival rate after the onset of blackfoot disease was 76.3%; the 10-year survival rate was 63.3%
and 15-year survival rate, 52.2%. The 50% survival point was 16 years after onset of the disease.
In a limited area on the southwest coast of
Taiwan where artesian well water with a high con-
centration ofarsenic has been used for more than 60
years, a high prevalence of chronic arsenicism has
been observed in recent years (1-3). It is well known
that hyperpigmentation, keratosis, and cancer are
the major manifestations ofchronic arsenicismfrom
any source (4), but peripheral circulatory disorders
have also been reported occasionally in chronic ar-
senicism (5-9). It seems reasonable to assume that
arsenic may be the common etiological factor for
skin cancer and blackfoot disease. A positive as-
sociation between the arsenic level of drinking
water and the prevalence of skin cancer in endemic
areas ofchronic arsenicism has been reported from
the district of Reichenstein, Silesia, Poland (7),
Cordoba Province, Argentina (10), and most re-
cently from Antofagasta, Chile (11). Although reli-
able information about the number ofcases ofarse-
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nical cancer of the skin is Reichenstein is not avail-
able, Arguello and Tello identified a total of 148
cases in Cordoba Province (12). There were no
statistical studies in either population group.
Regarding peripheral circulatory disorders, at
least 15 cases of chronic arsenicism have been re-
ported with gangrene of the extremities (5, 7, 8,
13-19). Although detailed pathologic observations
on autopsy specimens or amputated limbs are lack-
ing in the cases reported, the gangrene appears to
result from arteriosclerosis and thromboangiitis ob-
literans (5).
After a preliminary survey ofthe endemic area in
Taiwan, we have learned that a high percentage of
the inhabitants suffered from chronic arsenicism,
and a considerable number had arsenical skin
cancer or blackfoot disease, a folk term for a
peripheral vascular disorder resulting ingangrene of
extremities, especially the feet (1-3). The affected
area afforded us a unique opportunity to study sys-
tematically the epidemiologic, clinical, and
pathologic aspects ofboth thesediseases (Figs. 1 and
2).
August 1977 109FIGURE 1. Skin manifestations: (A) typical arsenical hyperpigmentation of skin in a 54 yr old male; (B) hyperpigmenta-
tion with Bowen's disease on the back in a 60 yr old male; (C) arsenical keratosis in a 39 year old male. (note
numerous nodular and papular keratotic lesions on palm and lateral surfaces offingers); (D) large dirty, fungating
tumor mass developed on the right sole in a 59 yr old male; biopsy revealed an epidermoid carcinoma.
Materials and Methods
Population of the Endemic Area
We use the term "endemic" area to refer to the
total region where artesian wells providing water
with a high concentration ofarsenic have been used
for a long time or are still used, and where a high
percentage of inhabitants suffer from skin lesions
associated with chronic arsenicism, i.e., hyperpig-
mentation, keratosis, and cancer. The total en-
demic area thus defined consists of two districts
(Peimen and Yi-Chu), three towns (Putai, Hsueh-
Chia, and Yen-Hsui), and three villages (two from
the suburb of Tainan City and one from the An-
Ting district). Census records obtained from vil-
lages in the endemic area showed that the entire
population at risk is 103,154 (51,289 males and
51,865 females), although approximately 10% ofthe
people are constantly away from home, either for
employment or for other reasons. The inhabitants
are mostly engaged in farming, fishing, or salt pro-
duction. The socioeconomic state of the people is
poor. As is usually true in rural areas in southern
Taiwan, the people subsist on food low in protein
and fat; carbohydrate, rice, and sweet potatoes
constitute the main part of their diet. The customs
and habits of the inhabitants do not differ from
those in other parts of Taiwan.
Artesian Wells
Artesian wells have been in use since the decade
1900-1910. In most parts of the area where artesian
wells are still in use, they are 100 to 280 m deep, 80%
being between 120 and 180 m in depth. In 1956 water
was piped to many places mostly from the reservoir
ofthe Chia-Nan irrigation system, this water having
an arsenic content of 0.01 ppm. In 1966 a tap water
supply was made available to the majority of the
endemic area in Tainan County. There will be no
more use of artesian wells in the study area. In the
villages surveyed, the arsenic content of the well
water ranged from 0.01 to 1.82 ppm, including four
shallow wells (20). The water from the artesian
wells was not always as high in arsenic content, for
Environmental Health PerspectivesFIGURE 2. Gangrene of extremities: (A) gangrene of right foot and spontaneous amputation of left toes in a 17 yr old
male; (B) gangrene of left foot in a 62 yr old male; (C) loss offirst and second toes ofright foot, and ulcer on left big
toe in a 54 yr old male: (D) gangrene of left second and third fingers in a 53 yr old female.
some from the neighborhood of the endemic area
had an arsenic content of only 0.01 ppm. Shallow
wells were usually almost free from arsenic (0.001
ppm).
Methods of Survey
By the end of 1965 a general survey of the entire
population of 40,421 in the endemic area had been
completed. Ten of the 37 villages are in Chai-yi
County, 25 in Tainan County, and 2 in a suburb of
Tainan City.
The survey was house-to-house and every
member of the family was examined. Particular at-
tention was paid to skin lesions, i.e., the pigmenta-
tion of unexposed body surfaces, keratoses (espe-
cially on palms and soles), and cancers. In addition,
the blood pressure of persons over age 20 was
taken; pulsation of the dorsalis pedis and posterior
tibial arteries was noted; evidence ofany peripheral
vascular disorder was recorded. The clinical ex-
aminations were done by two young doctors as-
sisted by a nurse and clerk, and all lesions they
found were checked by one or two of the experi-
enced senior members of our staff. A total of 303
arsenical skin cancers in 184 patients were studied
histologically. These lesions are discussed in detail
elsewhere (21). From the villages surveyed, we ex-
amined 142 water samples from 114 wells, ofwhich
all but four were artesian (Fig. 4). The villages in
FIGURE 3. Area of endemic chronic arsenic poisoning on
Taiwan.
August 1977 illthe endemic area that still used artesian wells at the
time of examination and had water with an arsenic
content over 0.01 ppm are shown in Figure 3. The
method used for determination of the arsenic con-
tent of the water was that of Natelson (22).
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FIGURE 4. Concentrations ofarsenic (ppm) in well water of sur-
veyed villages.
Method of Follow-Up Study of
Blackfoot Disease
A total of 1108 patients with blackfoot disease in
the entire endemic area were examined by the au-
thor himselfduring 1958 and 1975. There 669 males
aaid 439 females. Each patient was carefully
studied. Criteria for diagnosis depend upon (1) ob-
jective signs of ischemia, i.e., absence or diminu-
tion of arterial pulsations, pallor on elevation or
rubor on dependency of ischemic extremities, and
various degrees ofischemic changes in the skin and
(2) subjective symptoms ofischemia, i.e., intermit-
tent claudication, pain at rest, and ischemic
neuropathy. Follow-up was attempted by a variety
of methods, including direct follow-up physical ex-
amination, several mailings to patients, and search
ofdeath certificate files. By the end ofthefollow-up
period 528 patients had died, giving an overall fatal-
ity rate of 47.7%. A history of typical ischemic
symptoms such as numbness or intermittent claudi-
cation antecedent to Lhe ulcer or gangrene has been
used in estimating the date ofthe onset ofblackfoot
disease. The duration ofintake ofarsenical water at
the time of onset represents the period of time be-
tween first use of such intake and the time of onset
ofthe disease. Duration ofintake ofarsenical water
represents the duration of time during which the
patient started drinking artesian well waterup to the
time ofsurvey or up to the time ofchange ofsource
of drinking water. For native patients the duration
is estimated to be equivalent to their ages, but for
the patients who came from areas without artesian
wells the duration was counted as starting from the
year of their arrival.
Evaluation or rating of permanent disability has
long been recognized as an important and complex
subject. The percentage of permanent impairment
due to amputation has been taken from the litera-
ture (23).
Permanent impairment of the back and ex-
tremities is divided into five classes, from the mini-
mal nonimpairing (class 1) to the most severely im-
pairing (class 5). Percentage values representing the
impairment ofthe patient as awhole man were clas-
sified as follows; class 1, nonimpairing, 0% impair-
ment; class 2, mild impairing, 5-24% impairment;
class 3, moderate impairing, 25-49% impairment;
class 4, moderately severe impairing, 50-74% im-
pairment; class 5, most severely impairing, 75-90%
impairment.
The original classification did not have 1-4% of
the impairment of the whole man, but many minor
amputations occur in mild cases of Blackfoot dis-
ease. For this reason an additional class inter-
mediate between 1 and 2 was added to represent
very mild impairment, 1-4% of impairment.
Results
Age-Specific and Sex-Specific Prevalence of
Skin Cancer
Of the population of 40,421,428 (10.6/1000) had
arsenical skin cancer (Table 1). There were no pa-
tients under 20 years of age. The prevalence rate
increased markedly with age, except for females
above age 70. Over 10% ofthe people above age 60
were affected by skin cancer. The overall male-to-
female ratio was 2.9 to 1, with males having a higher
rate in all age groups above 30 years.
Table 1. Age-specific and sex-specific prevalence rate
for skin cancer.
Male Female Total
Age Per 1000 Number Per 1000 Number Per 1000 Number
0-19 0 0 - 0
20-29 1.0 2 1.1 3 1.1 5
30-39 9.7 20 1.5 4 5.0 24
40-49 25.9 40 8.0 16 15.7 56
50-59 80.8 99 28.9 38 53.7 137
60-69 124.8 92 57.0 40 91.9 132
70+ 209.6 57 53.8 17 125.6 74
Total 16.1 310 5.6 118 10.6 428
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Arsenic Concentration in Well Water
The villages surveyed were arbitrarily divided
into three groups, according to the arsenic concen-
tration in the well water being designated "low"
(below 0.3 ppm), "mid" (0.3-0.6 ppm), and "high"
(above 0.6 ppm) groups. A clear-cut ascending gra-
dient of prevalence of skin cancer from low (L) to
mid (M) to high (H) groups was found for both
sexes in the three age groups: e.g., 20-39 yr (H
11.5, M 2.2, L 1.3): 40-59 yr (H 72.0, M 32.6, L
4.9): 60 years and over (H 192.0, M 106.2, L 27.1),
as shown in Figure 5. Another group, "undeter-
mined," included those villages where either ar-
tesian wells with arsenic-polluted water were no
longer in use, or the difference in the arsenic con-
tent in waterfrom various artesian wells in the same
village was so great that it was impossible to put
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FIGURE 5. Age-specific and sex-specific prevalence rate per 1000
for skin cancer by arsenic concentration in well water.
them into any of the above-mentioned classifica-
tions. The prevalence rate of the "undetermined"
group was similar to that of the "mid" group.
Age-Specific and Sex-Specific Prevalence of
Blackfoot Disease
The overall prevalence was 0.9-1.1% for males
and 0.7% for females (Table 2). After age 40, the
rates for males were significantly higher than for
females. The prevalence rose steadily until age 70
for both sexes; after that, rates decreased. The
overall male-to-female ratio was 1.3 to 1.
Table 2. Age-specific and sex-specific prevalence rate
for blackfoot disease.
Male Female Total
Age Per 1000 Number Per 1000 Number Per 1000 Number
0-9 0.3 2 0 0.1 2
10-19 1.2 5 1.4 6 1.3 11
20-29 12.1 22 6.5 18 8.7 40
30-39 12.7 26 10.8 30 11.6 56
40-49 30.0 46 19.6 40 24.0 86
50-59 40.6 52 33.9 47 37.1 99
60-69 68.2 52 15.2 11 42.3 63
70+ 23.0 7 15.8 6 19.0 13
Total 10.7 212 7.3 158 9.0 370
Prevalence of Blackfoot Disease with Vary-
ing Arsenic Concentration in Well Water
According to the same above-mentioned classifi-
cation (low, mid and high groups) in the villages
surveyed, the prevalence rate for blackfoot disease
also revealed a clear-cut ascending gradient from
low to mid to high groups for both sexes in the three
age groups: e.g., 20-39 yr (H 14.2, M 13.2, L 4.5):
40-59 yr (H 46.9, M 32.0, L 10.5); 60 yr and over (H
61.4, M 32.2, L 20.3), as shown in Figure 6. The
greater the arsenic content, the higher the preva-
lence of blackfoot disease.
Combination of Skin Cancer and
Blackfoot Disease
In our survey of chronic arsenicism in a popula-
tion of 40,421 in 37 villages, we found 428 cases of
skin cancer and 370 cases of blackfoot disease giv-
ing an observed rate per 1000 of 10.59 and 8.96,
respectively. The combination of skin cancer and
blackfoot disease occurs in 61 cases, or 1.51 per
1000, whereas 4 cases, or 0.09 per 1000, are ex-
pected. Thus the ratio of observed to the expected
is 16.77. This ratio indicates that the coincidence of
the two conditions cannot be attributed to chance,
and incriminates a common or underlying factor,
namely, chronic arsenicism.
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FIGURE 6. Age-specific and sex-specific prevalence rate per 1000
for blackfoot disease by arsenic concentration in well water.
Relation of Water Supply to
Blackfoot Disease
It was determined that all of the patients with
blackfoot disease had consumed artesian well water
before the onset ofthe disease and none ofthe resi-
dents of the endemic area who had consumed only
surface water or water from shallow wells de-
veloped blackfoot disease. This appears to be be-
cause the shallow well water is almost free from
arsenic (0.001-0.017 ppm). In some parts of these
areas, a tap water supply was provided in 1956. The
change in the frequency of blackfoot disease since
that time is strong evidence supporting the arsenic
hypothesis. As shown in Table 3, in all periods
studied-1955 and before, between 1956 and 1965,
and between 1966 and 1975-there was no statisti-
cal difference in the age distribution between the
districts with water supplied by artesian well and
artesian well with a changeover to tap water in
1956. There were, however, more young patients in
the A group than in the B group during the period
1956-75. It should be particularly noted that while
there were no cases less than 20 yr old present in
the B group, there were five cases in this age group
in the A group during 1956-75. This fact is most
important, since it shows that no cases were found
among the inhabitants who were born after the tap
water supply was established. These supplemental
data support the conclusion that a close association
exists between the consumption of arsenical water
and the development of blackfoot disease.
Table 3. Incidence of blackfoot disease by age for areas served by
different water sources for various onset periods.
Incidence of blackfoot disease
1955 and before" 1956-1965" 1966-1975r
<40 :40 <40 :40 <40 :40
watersupply yr yr Total yr yr Total yr yr Total
Artesian well 75 75 150 117 292 409 38 203 241
Artesian well
changed to tap
waterin 1956 41 25 66 39 113 152 8 82 90
Total 116 100 216 156 405 561 46 285 331
(x2=2.71,0.IO<p<0.90.
bX2= 0.48. 0. IO < p < 0.90.
rx2 = 2.59. 0.10 < p < 0.90.
Hypothesis ofthe Cause ofBlackfoot Disease
The hypothesis is: the occurrence of endemic
blackfoot disease is directly related to the arsenic
content of artesian well water.
The patients with blackfoot disease were clas-
sified into one of the three groups according to the
arsenic concentration in the well water: high, mid,
and low groups. A definite gradient was associated
with the degree of exposure to arsenic (Table 4).
Furthermore, with each cohort (duration of intake
of arsenical water) a gradient in blackfoot patients
was associated with degree of arsenic concentra-
tion. During ofintake ofarsenical water and degree
of arsenic concentration were directly related and
the difference was statistically significant (X2 =
11.53, n = 4, 0.025 < p < 0.01). Thus exposure to
arsenic was found to be associated with an excess
of frequency of blackfoot disease in the high ex-
posure group oflongerconsumption ofartesian well
water. Thus, the hypothesis is sustained.
Degree ofSeverity in Relation to Duration of
Intake of Arsenical Water at the Time of
Onset
Table 5 shows that the group showing 0% im-
pairment increased and the 1-4%, 5-24% and
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rTable 4. Incidence ofblackfoot disease by duration ofintake of
arsenical water and degreeofarsenicconcentration."
Duration of Incidence ofblackfoot disease
intake of Low As Mid As High As
arsenical (0-0.29 (0.30-0.59 (>0.60
water, yr. ppm) ppm) ppm) Total
<20 7 41 36 84
20-39 15 101 78 194
>40 77 284 164 525
Total 99 426 278 803
(Ix2 = 11.53, n = 4, 0.025 < p < 0.01.
Table 5. Degree of severity in relation to duration of intake of
arsenical water at the time ofonset."
Duration of
intake of No. (%) showingvarious degrees ofimpairment
arsenical
water, yr 0% 1-4% 5-24% 25-49% 50-74% 75+% Total
30 20 30 32 8 1 121
0-19 (24.8) (16.5) (24.8) (26.4) ( 6.6) ( 0.8)
118 36 50 28 1 1 4 247
20-39 (47.8) (14.6) (20.2) (11.3) ( 4.5) ( 1.6)
239 79 133 211 73 5 741
40+ (32.2) (10.7) (17.9) (28.5) ( 9.9) ( 0.7)
387 135 213 271 92 10 1108
Total (34.6) (12.4) (18.6) (25.1) ( 8.4) ( 0.9)
(Ix2= 55.03, n = 10, p <0.001.
25-49% groups decreased in the 20-39 yr period of
intake ofarsenical water at the time ofonset. From
this, it can be supposed that this is a chronic type in
which disease goes on gradually. Thereafter cases
with both 25-49% and 50-74% impairment in-
creased tremendously at -40 yr intake of arsenical
water prior to time of onset. In general, the degree
of permanent impairment of patient is significantly
correlated with duration ofintake ofarsenical water
at the time ofonset (X2 = 55.03, n = 10, p <0.001).
As an aside, it may be noted that there is an acute
type of reaction; the patient develops (severe im-
pairment suddenly after a prolonged period of in-
take of arsenical water prior to the time of onset.
Generally speaking, group in which the duration of
intake of arsenical water at the time of onset was
below 19 yr did not correlate with the permanent
impairment in the 0%, 1-4%, 5-24%, and 25-49%
impairment groups. Those account for 24.8%,
16.5%, 24.8%, and 26.4%, respectively. This fact
indicates that there is an acute type which develops
rather severe impairment in a shorter duration of
intake of arsenical water at the time of onset.
Degree of Severity of Blackfoot Disease Re-
lated to Duration of Intake of Arsenical
Water
As shown inTable 6, it is also true that the degree
ofpermanent impairment is, in general, closely cor-
Table 6. Degree ofseverity in relation to duration ofintakeof
arsenical water."
Duration of
intake of No. (%) showing various degrees ofimpairrment
arsenical __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
water, yr O% 1-4% 5-24% 25-49% 50-74% 75 +% Total
30 13 14 13 3 1 74
0-19 (40.5) (16.6) (18.9) (16.6) ( 4.1) ( 1.4)
104 31 48 43 10 3 239
20-39 (43.5) (13.0) (20.1) (18.0) ( 0.4) ( 1.3)
186 55 98 145 54 5 543
40-59 (34.4) (10.1) (18.0) (26.7) ( 9.9) ( 0.9)
67 36 53 70 25 1 252
60+ (26.6) (14.3) (21.0) (27.8) ( 9.9) ( 0.4)
387 iu5 213 271 92 10 1108
Total (34.9) (12.2) (19.2) (24.5) ( 8.3) ( 0.9)
(x2 = 34.17, n = 15,p <0.005.
related with duration of intake of arsenical water,
especially in severe cases. The percentage of im-
pairment in 60 yr is much lower than that of the
patients ingesting arsenical water for less than 40
yr. On the contrary, the percentage of moderate
impairment increased with longer duration ofintake
ofarsenical water. The differences ofpercentage of
permanent impairment among different period ofin-
take of arsenical water were statistically significant
(X2=34.17, n=15, p<0.005). Thus the degree of
permanent impairment of patients with blackfoot
disease was noted to be directly related to duration
of intake of arsenical water.
Mean Age at Death of Patients with Black-
foot Disease and Arsenic Level in the Well
Water
Of the 528 deaths, for 379 patients with blackfoot
disease, the mean age ofdeath was found to be 58 +
12.6 yr, 60.0 + 12.7 yr, and 63.7 + 12.2 yr, respec-
tively, for high, mid, and low As levels (Table 7).
The difference of mean age at death between high
and low groups was statistically significant
(p<O.Ol). The mean age of death for patients with
blackfoot disease was significantly lower in areas of
high arsenic content than in areas of low arsenic
content of the well water.
Table 7. Age at death ofpatients with blackfoot disease by
arsenic level in the well water.
As concn
in well Age at death, yr
water" 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70+ Total
High (1) 1 0 3 5 23 31 42 22 127
Mid(2) 1 0 4 8 23 59 64 44 203
Low(3) 0 0 2 1 2 7 21 16 49
Total 2 0 9 14 48 97 127 82 379
at,2: p = 0.147, NS, t13: p = 0.006, p < 0.01; t2-3: p = 0.062, NS.
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Blackfoot Disease
The relationship between age at onset and subse-
quent fatality is shown in Table 8. The greatest
concentration of age at onset was in the 50-59 age
group. The case-fatality rate increased linearly with
age at the time of onset, with greater risk for older
patients, reaching 66.3% by 70 yr or over, in gen-
eral, the older the age group the higher the rate.
Table 8. Case-fatality according to age at onset.
Age. No. of No. Case-fatality
yr patients dying rate, %
1-9 26 7 26.9
10-19 85 20 23.5
20-29 89 20 22.5
30-39 150 50 33.3
40-49 216 111 51.4
50-59 258 139 53.9
60-69 195 122 62.6
70+ 89 59 66.3
Total 1108 528 47.7
Causes of Death in Patients with Skin
Cancer and Patients with Blackfoot Disease
During the follow-up period of 18 yr for blackfoot
disease, 528 of 1108 patients died. This is an overall
fatality rate of 47.7%. Another 10-yr follow-up
period for skin cancer showed 244 of 428 patients
died, giving a 57.0% fatality rate.
An analysis was made of the causes of death up
to 1975 in patients with these two diseases as com-
pared with that in the general population of the en-
demic area((Table 9). The most common cause of
death in patients with skin cancer or blackfoot dis-
ease was carcinoma of various sites, 27.9% in skin
cancer and 18.8% in blackfoot disease. Cardiovas-
cular disease was also responsible for 15.7% of
death in patients with blackfoot disease. In general,
in the population of the endemic area in 1966,
cancer accounted for 13.1% of the deaths and car-
diovascular disease 9.1%, whereas for the whole
population ofTaiwan in 1966 cancer and cardiovas-
cular disease accounted for 7.9 and 8.1% of cases,
respectively.
Death Rate of Patients with
Blackfoot Disease
Table 10 shows the death rate among the patients
with blackfoot disease. An annual death rate per
1000, as might be expected, increased somewhat
with age, 528 deaths in 12,461 patient-years in this
series give an annual death rate of 42.4 per 1000.
Table 9. Causes of death in patients with skin cancer anJ patients
with blackfoot disease.
Blackfoot General
Skin cancer disease population in
patients patients endemic area
Cause ofdeath No. % No. % No. %
Cancer 68 27.9 99 18.8 125 13.1
Lung 15 6.1 21 4.0 21 2.2
Skin 15 6.1 12 2.3 3 0.3
Bladder 10 4.1 17 3.2 16 1.7
Liver 6 2.5 21 4.0 17 1.8
Colon 5 2.0 3 0.6 12 1.3
Kidney 5 2.0 - 0 - 0
Stomach 3 1.2 4 0.8 13 1.4
Nasal cavity 2 0.8 5 0.9 16 1.7
Bone 2 0.8 4 0.8 2 0.2
Uterus 1 0.4 2 0.4 6 0.6
Esophagus - 0 4 0.8 2 0.2
Miscellaneous 4 1.6 6 1.1 17 1.8
Cardiovasculardisease 30 12.3 83 15.7 87 9.1
Gangrene 7 2.9 70 13.3 0
Cerebrovasculardisease 32 13.1 63 12.0 91 9.6
Respiratory disease 46 18.9 100 18.9 231 25.1
Pulmonary tuberculosis 10 4.1 41 7.8 55 5.8
Pneumonia 17 7.0 28 5.3 117 12.3
Others 19 7.8 31 5.9 67 7.0
Disease ofthe 13 5.3 34 6.4 118 12.4
alimentary tract
Senility 12 4.9 22 4.2 50 5.3
Renal disease 7 2.9 21 4.0 34 3.6
Miscellaneous 13 5.3 30 5.7 207 21.8
Unknown 16 6.6 6 1.1 0
Total 244 528 951
Table 10. Calculation of death rates specific for age for blackfoot
disease (based on patient-years).
Patient- Annual death
Age at onset, No. of years No. of rate per
yr patients at risk deaths 1000
1-9 26 545 7 12.8
10-19 85 1869 20 10.7
20-29 89 1572 20 12.7
30-39 150 2279 50 21.9
40-49 216 2588 111 42.9
50-59 258 2207 139 45.2
60-69 195 1108 122 110.1
70+ 89 293 59 201.4
Total 1,108 12,461 528 42.4
Survival Rate of Patients with
Blackfoot Disease
Survival rate represents the period of time be-
tween the onset ofdisease and the end ofthe study.
Figure 7 shows the survival rate each year after the
onset of disease for amputated, nonamputated, and
total patients. The 5-yr survival rates after onset of
blackfoot disease for total, amputated, and nonam-
putated patients were 76.3%, 73.5%, and 80.9%, re-
spectively. The 10-yr survival rates were 63.3%,
60.0%, and 68.8%, respectively; 15-yr survival rate,
Environmental Health Perspectives 1652.2%, 48.2%, and 60.0%, respectively. The 50%
survival point for total, amputated, and nonampu-
tated patients were 16, 14, and 21 yr, respectively.
The annual death rate per 1000 by the end of 15 yr
was 51.6 per 1000 in amputated patients, 38.1 per
1000 in nonamputated patients, and 46.0 per 1000 in
total blackfoot patients. It must be pointed out that
many factors, such as duration ofintake ofarsenical
water, may influence the results.
loop
80
60
60 '"
t 40 _
20 ,-_,s\~
20
0 5 10 15 20 25 30 35 40
Years after Onset of Blackfoot Disease
FIGURE 8. Survival rate of patients with blackfoot disease in
relation to duration of intake of arsenical water: (A) 0-19 yr;
(B) 20-39 yr; (C) 40-59 yr; (D) >60 yr.
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FIGURE 7. Survival rate of patients with blackfoot disease: (A)
amputated patients; (B) nonamputated patients; (C) total pa-
tients.
Survival Rate of Patients with Blackfoot
Disease Related to Duration of Intake of
Arsenical Water
It is also worthwhile to give special consideration
to the relationship between the survival rate and the
duration of intake of arsenical water. The duration
of intake of arsenical water was divided into four
groups; 1-19 yr, 20-39 yr, 40-59 yr, and >60 yr. As
shown in Figure 8, there was a clear-cut descending
gradient of survival rate from the >60 yr group to
40-59 yr group to the 1-19 yr group. The 50% survi-
val points for patients with 1-19, 20-39, 40-59, and
>60 yr intake of arsenical water were 25, 31, 14,
and 5 yr, respectively. Annual death rates per 1000
by the end of 15 yr were 5.9 per 1000 in the 1-19 yr
intake group 14.7% per 1000 in the 20-39 yr group,
50.8 per 1000 in the 40-59 yr group and 112.2 per
1000 in the >60 yr group.
Discussion
Although arsenic is notorious primarily for its
acute toxicity, chronic toxicity is also a problem.
Despite the many papers dealing with the medical,
dietary, and occupational etiology of arsenical
cancer, no reliable data on the frequency of arseni-
cal cancer in a total population at risk are available
in the literature. Arsenic is a common mineral, and
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in many parts of the world it appears in drinking
water obtained from wells drilled into arsenic-rich
ground strata. The classical examples of toxicity
from consumption of arsenic-polluted public drink-
ing water are presented by the occurrence of skin
cancer in members of some population groups, re-
siding in the district of Reichenstein, Silesia, Po-
land (7), in Cordoba Province, Argentina (10) and
recently in Antofagasta, Chile (11). Although a
positive association between the arsenic level of
drinking water and the prevalence of skin cancer in
endemic areas of chronic arsenicism has been re-
ported from the above-mentioned area, a negative
finding was also noted in Lane County, Oregon,
U. S. (24). The Lane County water arsenic levels
averaged much lower than those reported from
Taiwan and Antofagasta (11), so that they sug-
gested that their increasing incidence of basal cell
carcinoma might be potentiated by urban air pollu-
tants.
Skin cancer, which is very common in
Caucasians, has a relatively low incidence among
Chinese in Taiwan-only 2.9% (25). Skin cancers
usually occur on exposed surfaces, i.e., on the
head, face, and extremities, and often are epider-
moid or basal cell carcinomas. These features are
also present in patients with ordinary skin cancers
in Taiwan, but do not appear in the present series of
arsenical cancer cases. The most common type of
lesion (26) was intraepidermal carcinoma (51.7%),
and the body areas most frequently involved were
unexposed surfaces (74.5%). In addition, the ex-
tremely high percentage of cases with multiple skin
cancer (99.5%) was characteristic of our series.
In general, the prevalence of skin cancer, hyper-
pigmentation, and keratosis increased steadily with
age. As the inhabitants of the endemic area started
using artesian wells for drinking water more than 55
yr ago, the period of exposure to arsenic-polluted
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at the time of examination. It was difficult to elicit
from patients the age at onset of arsenical cancer,
because most ofthe patients were unable to name a
date. We know from this study that the youngest
cancer patient was 25, the youngest with hyperpig-
mentation was 5, and the youngest with keratosis
was 15. This means that hyperpigmentation can
occur in patients who have been exposed for at least
5 years, keratosis for 14 yr, and cancer for 24.
There was a similar finding for blackfoot disease,
which occurred in 8.9 per 1000 population. His-
tologically, blackfoot disease can be divided into
two reaction groups, arteriosclerosis obliterans and
thromboangiitis obliterans. The fundamental vascu-
lar change in both groups is severe arteriosclerosis
leading to arteriosclerotic gangrene in 69.2% (3).
Peripheral circulatory disorders occasionally occur
in chronic arsenicism (5-9). At least 15 cases of
chronic arsenicism have been reported with gan-
grene ofthe extremities (5, 7, 8, 13-19). Only two of
them were females. The age ranged from 33 to 54.
Although detailed pathological observations on au-
topsy specimens or amputated limbs are lacking in
the cases reported, the gangrene appears to result
from arteriosclerosis and thromboangiitis obliterans
(5). Is arsenic an agent capable of eliciting arterio-
sclerosis? Hueper (27), in a comprehensive review of
the subject of arteriosclerosis, has outlined arsenic
as one of the vasodilating depressors. Chronic ex-
posure to arsenical compounds may result in gan-
grene of extremities which he thought of as the
equivalent of focal anoxemic myocardial and cere-
bral necrosis caused by those agents which exert
their main vasodilating effects on the cerebral and
coronary arteries.
A dose-response relationship between blackfoot
disease and the arsenic level of drinking water was
similar to that observed for skin cancer. One final
source of evidence to support this positive associa-
tion is obtained when one examines the frequency
of blackfoot disease among young children who
were born after the tap water supply was estab-
lished in 1956. No new cases have been found
among those children less than 20 yr old in the area
supplied with tap water. However people who
changed to tap water could still be affected with
blackfoot disease if they had a previous history of
drinking artesian well water.
The duration of intake of arsenical water also
much influences the severity of permanent impair-
ment of the extremities, mean age at death, and
survival rate ofpatients with blackfoot disease. We
found that the association ofblackfoot disease with
hyperpigmentation, keratosis, or skin cancer was
not a coincidental or chance occurrence, which
strengthened the likelihood of a causal relationship
between blackfoot disease and chronic arsenicism.
This leads to the conclusion that skin cancer and
blackfoot disease are both part of the entity of
chronic arsenicism.
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